| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Engineering | 55 | 2018 | 936 | 10.150 |
Why?
|
| Genome, Bacterial | 44 | 2018 | 796 | 5.250 |
Why?
|
| Escherichia coli | 66 | 2018 | 4213 | 5.000 |
Why?
|
| Genome, Human | 50 | 2018 | 4456 | 3.690 |
Why?
|
| Gene Targeting | 12 | 2015 | 841 | 3.450 |
Why?
|
| DNA | 52 | 2018 | 7214 | 3.260 |
Why?
|
| Genome | 28 | 2018 | 1754 | 3.140 |
Why?
|
| Biotechnology | 11 | 2018 | 283 | 2.970 |
Why?
|
| Sequence Analysis, DNA | 53 | 2016 | 4785 | 2.750 |
Why?
|
| Endonucleases | 12 | 2017 | 371 | 2.700 |
Why?
|
| RNA Editing | 11 | 2015 | 150 | 2.630 |
Why?
|
| Synthetic Biology | 11 | 2018 | 187 | 2.570 |
Why?
|
| Escherichia coli Proteins | 23 | 2018 | 1058 | 2.310 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 39 | 2016 | 3810 | 2.270 |
Why?
|
| DNA, Bacterial | 19 | 2018 | 1478 | 2.120 |
Why?
|
| Induced Pluripotent Stem Cells | 20 | 2019 | 1891 | 2.100 |
Why?
|
| Genes, Synthetic | 6 | 2016 | 88 | 1.820 |
Why?
|
| Genetic Code | 6 | 2016 | 139 | 1.780 |
Why?
|
| Gene Expression Profiling | 40 | 2018 | 9549 | 1.670 |
Why?
|
| Oligonucleotides | 12 | 2017 | 563 | 1.660 |
Why?
|
| Bacterial Proteins | 24 | 2017 | 3840 | 1.610 |
Why?
|
| High-Throughput Nucleotide Sequencing | 21 | 2018 | 3671 | 1.610 |
Why?
|
| Saccharomyces cerevisiae | 32 | 2014 | 2682 | 1.600 |
Why?
|
| Computational Biology | 32 | 2017 | 3562 | 1.580 |
Why?
|
| Systems Biology | 8 | 2014 | 482 | 1.520 |
Why?
|
| Biosensing Techniques | 5 | 2018 | 662 | 1.460 |
Why?
|
| Recombination, Genetic | 8 | 2014 | 1526 | 1.440 |
Why?
|
| Genomics | 22 | 2017 | 5928 | 1.410 |
Why?
|
| RNA | 12 | 2018 | 2727 | 1.350 |
Why?
|
| Amino Acids | 11 | 2018 | 1716 | 1.270 |
Why?
|
| Gene Expression Regulation, Bacterial | 18 | 2018 | 1137 | 1.270 |
Why?
|
| Base Sequence | 46 | 2017 | 12430 | 1.260 |
Why?
|
| Clostridium | 4 | 2015 | 100 | 1.260 |
Why?
|
| Protein Biosynthesis | 14 | 2018 | 2094 | 1.240 |
Why?
|
| Cellulose | 4 | 2014 | 117 | 1.230 |
Why?
|
| Polymerase Chain Reaction | 22 | 2014 | 6086 | 1.210 |
Why?
|
| Genetic Techniques | 9 | 2017 | 428 | 1.200 |
Why?
|
| Chromosome Mapping | 16 | 2016 | 4625 | 1.120 |
Why?
|
| Genes, Essential | 5 | 2016 | 185 | 1.120 |
Why?
|
| Transcription, Genetic | 33 | 2018 | 7609 | 1.100 |
Why?
|
| Genes, Bacterial | 16 | 2016 | 1076 | 1.090 |
Why?
|
| RNA, Messenger | 22 | 2018 | 12806 | 1.060 |
Why?
|
| Genome, Fungal | 8 | 2013 | 203 | 1.030 |
Why?
|
| Models, Genetic | 20 | 2015 | 3449 | 1.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 7 | 2014 | 340 | 1.000 |
Why?
|
| Transcription Factors | 24 | 2018 | 12174 | 0.940 |
Why?
|
| Biosynthetic Pathways | 2 | 2016 | 138 | 0.940 |
Why?
|
| Codon | 7 | 2016 | 599 | 0.930 |
Why?
|
| Sequence Analysis, Protein | 7 | 2014 | 265 | 0.930 |
Why?
|
| Chromosomes, Bacterial | 7 | 2012 | 281 | 0.920 |
Why?
|
| Bioengineering | 3 | 2016 | 101 | 0.910 |
Why?
|
| Sequence Analysis, RNA | 9 | 2015 | 2041 | 0.910 |
Why?
|
| Bacteriophage lambda | 4 | 2012 | 142 | 0.890 |
Why?
|
| DNA-Directed DNA Polymerase | 6 | 2016 | 481 | 0.880 |
Why?
|
| Molecular Sequence Data | 40 | 2015 | 17629 | 0.880 |
Why?
|
| Molecular Biology | 9 | 2015 | 573 | 0.880 |
Why?
|
| Embryonic Development | 3 | 2018 | 724 | 0.860 |
Why?
|
| Biological Evolution | 5 | 2018 | 1077 | 0.850 |
Why?
|
| Streptococcus pyogenes | 6 | 2017 | 293 | 0.830 |
Why?
|
| Proteome | 10 | 2013 | 1891 | 0.820 |
Why?
|
| Algorithms | 38 | 2018 | 14201 | 0.810 |
Why?
|
| Evolution, Molecular | 14 | 2018 | 1894 | 0.800 |
Why?
|
| Software | 15 | 2017 | 4479 | 0.780 |
Why?
|
| Models, Biological | 18 | 2015 | 9499 | 0.780 |
Why?
|
| Cell-Free System | 3 | 2018 | 340 | 0.770 |
Why?
|
| Gene Expression Regulation | 20 | 2019 | 11932 | 0.770 |
Why?
|
| Soil Microbiology | 3 | 2015 | 92 | 0.770 |
Why?
|
| Metabolic Networks and Pathways | 6 | 2016 | 800 | 0.740 |
Why?
|
| Gene Expression Regulation, Fungal | 10 | 2012 | 497 | 0.730 |
Why?
|
| Gene Library | 12 | 2018 | 1062 | 0.720 |
Why?
|
| Organisms, Genetically Modified | 3 | 2015 | 63 | 0.720 |
Why?
|
| Enzymes | 5 | 2015 | 254 | 0.720 |
Why?
|
| Multienzyme Complexes | 5 | 2012 | 665 | 0.720 |
Why?
|
| Transcriptional Activation | 4 | 2016 | 1750 | 0.720 |
Why?
|
| Databases, Genetic | 13 | 2015 | 1758 | 0.700 |
Why?
|
| Cloning, Molecular | 14 | 2018 | 4168 | 0.700 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 8 | 2004 | 792 | 0.700 |
Why?
|
| Life | 2 | 2018 | 13 | 0.700 |
Why?
|
| Codon, Terminator | 4 | 2014 | 125 | 0.690 |
Why?
|
| Biochemistry | 2 | 2014 | 116 | 0.690 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 1209 | 0.660 |
Why?
|
| Human Genome Project | 6 | 2016 | 202 | 0.660 |
Why?
|
| Nanopores | 2 | 2016 | 48 | 0.650 |
Why?
|
| Saccharomyces cerevisiae Proteins | 12 | 2014 | 1839 | 0.650 |
Why?
|
| Nanotechnology | 7 | 2017 | 714 | 0.640 |
Why?
|
| Phenotype | 20 | 2017 | 16731 | 0.640 |
Why?
|
| Nucleic Acid Conformation | 10 | 2015 | 901 | 0.640 |
Why?
|
| Haplotypes | 11 | 2016 | 2725 | 0.620 |
Why?
|
| Vibrio | 1 | 2018 | 40 | 0.610 |
Why?
|
| DNA-Binding Proteins | 19 | 2013 | 9618 | 0.610 |
Why?
|
| Alleles | 13 | 2018 | 6901 | 0.610 |
Why?
|
| Containment of Biohazards | 2 | 2015 | 39 | 0.610 |
Why?
|
| Open Reading Frames | 15 | 2013 | 818 | 0.600 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2018 | 10 | 0.600 |
Why?
|
| HEK293 Cells | 10 | 2018 | 4290 | 0.600 |
Why?
|
| Genetic Vectors | 9 | 2018 | 3412 | 0.600 |
Why?
|
| Genomic Library | 4 | 2015 | 189 | 0.590 |
Why?
|
| Archaeal Proteins | 1 | 2018 | 57 | 0.590 |
Why?
|
| Genes | 7 | 2014 | 1824 | 0.590 |
Why?
|
| Ribosomes | 4 | 2017 | 499 | 0.580 |
Why?
|
| DNA, Single-Stranded | 5 | 2013 | 351 | 0.580 |
Why?
|
| Protein Engineering | 6 | 2018 | 553 | 0.580 |
Why?
|
| Trans-Activators | 5 | 2016 | 2858 | 0.570 |
Why?
|
| DNA, Intergenic | 1 | 2018 | 108 | 0.570 |
Why?
|
| Metabolism | 3 | 2003 | 193 | 0.570 |
Why?
|
| Targeted Gene Repair | 2 | 2015 | 20 | 0.570 |
Why?
|
| Plasmids | 9 | 2018 | 2269 | 0.560 |
Why?
|
| Proteomics | 8 | 2017 | 3914 | 0.560 |
Why?
|
| Gene Deletion | 6 | 2015 | 2674 | 0.550 |
Why?
|
| Cytidine Deaminase | 2 | 2016 | 249 | 0.550 |
Why?
|
| Cell Fractionation | 2 | 2017 | 247 | 0.550 |
Why?
|
| Selection, Genetic | 4 | 2016 | 878 | 0.540 |
Why?
|
| Promoter Regions, Genetic | 16 | 2014 | 5801 | 0.540 |
Why?
|
| Safety | 3 | 2015 | 1161 | 0.540 |
Why?
|
| DNA Probes | 4 | 2009 | 543 | 0.530 |
Why?
|
| Ribosomal Proteins | 3 | 2017 | 370 | 0.530 |
Why?
|
| Bacterial Outer Membrane Proteins | 3 | 2014 | 404 | 0.530 |
Why?
|
| Longevity | 6 | 2015 | 1077 | 0.520 |
Why?
|
| Genes, Fungal | 9 | 2007 | 440 | 0.520 |
Why?
|
| Sequence Alignment | 8 | 2014 | 2179 | 0.520 |
Why?
|
| Genetic Variation | 14 | 2017 | 6611 | 0.520 |
Why?
|
| Virus Inactivation | 1 | 2015 | 19 | 0.510 |
Why?
|
| Viral Proteins | 4 | 2013 | 1802 | 0.510 |
Why?
|
| Endodeoxyribonucleases | 2 | 2016 | 166 | 0.510 |
Why?
|
| Directed Molecular Evolution | 3 | 2016 | 165 | 0.510 |
Why?
|
| Mole Rats | 2 | 2014 | 28 | 0.500 |
Why?
|
| Deoxyribonucleases | 2 | 2014 | 209 | 0.500 |
Why?
|
| Information Storage and Retrieval | 3 | 2016 | 831 | 0.500 |
Why?
|
| Retroviridae Infections | 1 | 2015 | 148 | 0.490 |
Why?
|
| DNA Barcoding, Taxonomic | 2 | 2014 | 134 | 0.490 |
Why?
|
| Cytological Techniques | 1 | 2017 | 218 | 0.490 |
Why?
|
| Mutation | 32 | 2018 | 30266 | 0.480 |
Why?
|
| Animals | 78 | 2018 | 169335 | 0.480 |
Why?
|
| Mutagenesis | 7 | 2016 | 1229 | 0.480 |
Why?
|
| Drug Resistance, Bacterial | 5 | 2013 | 1063 | 0.470 |
Why?
|
| Genotype | 11 | 2017 | 13048 | 0.470 |
Why?
|
| Genetic Loci | 4 | 2018 | 2630 | 0.470 |
Why?
|
| Chitin | 1 | 2014 | 34 | 0.470 |
Why?
|
| Integrases | 2 | 2017 | 520 | 0.470 |
Why?
|
| RNA, Small Untranslated | 6 | 2014 | 77 | 0.470 |
Why?
|
| Bacteriophage T4 | 1 | 2014 | 33 | 0.460 |
Why?
|
| Endogenous Retroviruses | 1 | 2015 | 112 | 0.460 |
Why?
|
| DNA Footprinting | 3 | 2004 | 97 | 0.460 |
Why?
|
| DNA, Complementary | 7 | 2015 | 1990 | 0.460 |
Why?
|
| RNA, Ribosomal, 23S | 2 | 2013 | 54 | 0.460 |
Why?
|
| Aging | 6 | 2009 | 8745 | 0.450 |
Why?
|
| Conjugation, Genetic | 2 | 2011 | 116 | 0.450 |
Why?
|
| Electrodes | 1 | 2016 | 617 | 0.450 |
Why?
|
| DNA Primers | 8 | 2014 | 2827 | 0.450 |
Why?
|
| Glycoside Hydrolases | 1 | 2014 | 135 | 0.450 |
Why?
|
| Mammoths | 1 | 2013 | 11 | 0.450 |
Why?
|
| Proteins | 10 | 2018 | 6011 | 0.450 |
Why?
|
| Inosine | 2 | 2013 | 129 | 0.450 |
Why?
|
| Binding Sites | 23 | 2015 | 6023 | 0.440 |
Why?
|
| Humans | 157 | 2019 | 768970 | 0.440 |
Why?
|
| Phylogeny | 16 | 2015 | 2843 | 0.440 |
Why?
|
| Deoxyribonuclease I | 2 | 2013 | 228 | 0.430 |
Why?
|
| Bioreactors | 1 | 2014 | 246 | 0.430 |
Why?
|
| Gene Expression | 10 | 2017 | 7603 | 0.430 |
Why?
|
| Bacteria | 6 | 2015 | 2216 | 0.420 |
Why?
|
| Biology | 2 | 2005 | 292 | 0.420 |
Why?
|
| Computer Storage Devices | 1 | 2012 | 9 | 0.420 |
Why?
|
| DNA Polymerase I | 1 | 2012 | 44 | 0.410 |
Why?
|
| DNA Polymerase beta | 1 | 2012 | 19 | 0.410 |
Why?
|
| Arginine | 1 | 2016 | 932 | 0.410 |
Why?
|
| Mental Processes | 1 | 2014 | 246 | 0.410 |
Why?
|
| Flow Cytometry | 8 | 2018 | 5906 | 0.400 |
Why?
|
| Mass Spectrometry | 8 | 2011 | 2204 | 0.400 |
Why?
|
| Biofuels | 5 | 2015 | 45 | 0.400 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2012 | 167 | 0.400 |
Why?
|
| Dependovirus | 2 | 2016 | 721 | 0.390 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 2013 | 706 | 0.390 |
Why?
|
| Genetic Privacy | 2 | 2010 | 59 | 0.390 |
Why?
|
| RNA, Fungal | 6 | 2005 | 156 | 0.390 |
Why?
|
| Caulobacter crescentus | 1 | 2011 | 24 | 0.390 |
Why?
|
| Proteobacteria | 2 | 2009 | 47 | 0.380 |
Why?
|
| Nucleotides | 3 | 2016 | 455 | 0.380 |
Why?
|
| Adenosine | 2 | 2013 | 822 | 0.380 |
Why?
|
| Databases, Protein | 4 | 2013 | 390 | 0.380 |
Why?
|
| Cell Line | 16 | 2016 | 15604 | 0.380 |
Why?
|
| Fungi | 1 | 2014 | 345 | 0.380 |
Why?
|
| Computer Simulation | 13 | 2018 | 6291 | 0.370 |
Why?
|
| Polymorphism, Single Nucleotide | 15 | 2018 | 16053 | 0.370 |
Why?
|
| DNA Ligases | 2 | 2008 | 81 | 0.370 |
Why?
|
| Genes, Reporter | 4 | 2018 | 1524 | 0.370 |
Why?
|
| Mutagenesis, Insertional | 4 | 2013 | 662 | 0.370 |
Why?
|
| Brain | 13 | 2016 | 27453 | 0.370 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2016 | 3744 | 0.370 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 1313 | 0.360 |
Why?
|
| Amino Acid Sequence | 23 | 2017 | 13427 | 0.360 |
Why?
|
| Nucleic Acid Hybridization | 8 | 2010 | 1305 | 0.360 |
Why?
|
| Mycoplasma | 2 | 2004 | 146 | 0.360 |
Why?
|
| Genetic Research | 4 | 2015 | 173 | 0.360 |
Why?
|
| Biomedical Research | 5 | 2017 | 3463 | 0.350 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 3775 | 0.350 |
Why?
|
| Nanostructures | 3 | 2012 | 553 | 0.350 |
Why?
|
| Sequence Analysis | 3 | 2007 | 240 | 0.340 |
Why?
|
| Genetic Testing | 5 | 2016 | 3591 | 0.340 |
Why?
|
| Plants | 3 | 2017 | 332 | 0.340 |
Why?
|
| Cellulase | 1 | 2009 | 10 | 0.340 |
Why?
|
| Bacteria, Aerobic | 1 | 2009 | 24 | 0.340 |
Why?
|
| Homozygote | 1 | 2014 | 1780 | 0.340 |
Why?
|
| B-Lymphocytes | 4 | 2018 | 4794 | 0.340 |
Why?
|
| Peptide Library | 7 | 2014 | 351 | 0.330 |
Why?
|
| Manganese | 1 | 2012 | 394 | 0.330 |
Why?
|
| Recombinant Proteins | 6 | 2017 | 6512 | 0.330 |
Why?
|
| DNA Replication | 2 | 2016 | 1428 | 0.330 |
Why?
|
| Neurogenesis | 2 | 2019 | 865 | 0.330 |
Why?
|
| Exons | 6 | 2015 | 2395 | 0.320 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1143 | 0.320 |
Why?
|
| Blotting, Western | 1 | 2017 | 5033 | 0.320 |
Why?
|
| Database Management Systems | 3 | 2002 | 263 | 0.320 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2018 | 1966 | 0.320 |
Why?
|
| Microscopy, Fluorescence | 7 | 2017 | 2635 | 0.320 |
Why?
|
| Magnesium | 2 | 2012 | 816 | 0.320 |
Why?
|
| Multigene Family | 6 | 2010 | 1082 | 0.320 |
Why?
|
| RNA Interference | 4 | 2016 | 2835 | 0.320 |
Why?
|
| RNA Ligase (ATP) | 1 | 2008 | 9 | 0.320 |
Why?
|
| Metagenome | 2 | 2010 | 465 | 0.320 |
Why?
|
| Environment | 3 | 2011 | 1122 | 0.320 |
Why?
|
| Inverted Repeat Sequences | 3 | 2013 | 60 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2009 | 229 | 0.320 |
Why?
|
| Gene Silencing | 3 | 2017 | 1505 | 0.310 |
Why?
|
| Operon | 10 | 2017 | 371 | 0.310 |
Why?
|
| Digestive System | 1 | 2009 | 244 | 0.310 |
Why?
|
| Neurosciences | 1 | 2013 | 385 | 0.310 |
Why?
|
| Viral Vaccines | 1 | 2014 | 596 | 0.310 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2013 | 2749 | 0.310 |
Why?
|
| Models, Molecular | 12 | 2016 | 5404 | 0.310 |
Why?
|
| Mice | 38 | 2018 | 82072 | 0.310 |
Why?
|
| Tissue Donors | 1 | 2018 | 2382 | 0.300 |
Why?
|
| Fluorescence | 3 | 2016 | 757 | 0.300 |
Why?
|
| Databases, Nucleic Acid | 2 | 2009 | 204 | 0.300 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 1038 | 0.300 |
Why?
|
| Robotics | 2 | 2012 | 826 | 0.300 |
Why?
|
| Bacteroidetes | 1 | 2008 | 84 | 0.300 |
Why?
|
| DNA Mismatch Repair | 1 | 2011 | 432 | 0.300 |
Why?
|
| Immunity | 1 | 2014 | 1003 | 0.300 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2011 | 279 | 0.300 |
Why?
|
| Organ Specificity | 2 | 2009 | 1970 | 0.290 |
Why?
|
| Protein Interaction Mapping | 3 | 2013 | 621 | 0.290 |
Why?
|
| Drosophila melanogaster | 3 | 2016 | 1726 | 0.290 |
Why?
|
| Biomass | 5 | 2011 | 135 | 0.290 |
Why?
|
| Conserved Sequence | 6 | 2007 | 1162 | 0.290 |
Why?
|
| Actinobacteria | 1 | 2008 | 62 | 0.290 |
Why?
|
| Metagenomics | 5 | 2015 | 474 | 0.290 |
Why?
|
| Zinc Fingers | 3 | 2013 | 577 | 0.290 |
Why?
|
| Green Fluorescent Proteins | 5 | 2018 | 2067 | 0.290 |
Why?
|
| DNA, Circular | 1 | 2007 | 97 | 0.290 |
Why?
|
| Werner Syndrome | 1 | 2007 | 12 | 0.290 |
Why?
|
| Gene Regulatory Networks | 5 | 2019 | 1752 | 0.290 |
Why?
|
| Substrate Specificity | 8 | 2017 | 1751 | 0.290 |
Why?
|
| Ecosystem | 5 | 2015 | 494 | 0.290 |
Why?
|
| Prochlorococcus | 4 | 2007 | 8 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 7 | 2016 | 7478 | 0.280 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 2395 | 0.280 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 1887 | 0.280 |
Why?
|
| Viruses | 2 | 2010 | 373 | 0.280 |
Why?
|
| Base Pair Mismatch | 3 | 2012 | 93 | 0.280 |
Why?
|
| MicroRNAs | 7 | 2015 | 3811 | 0.270 |
Why?
|
| Allosteric Regulation | 3 | 2018 | 424 | 0.270 |
Why?
|
| Antibodies | 2 | 2014 | 2422 | 0.270 |
Why?
|
| Bioethics | 1 | 2008 | 118 | 0.270 |
Why?
|
| Competitive Behavior | 1 | 2007 | 78 | 0.270 |
Why?
|
| Pan troglodytes | 1 | 2007 | 224 | 0.270 |
Why?
|
| Cell Culture Techniques | 5 | 2015 | 1667 | 0.270 |
Why?
|
| Microbial Viability | 3 | 2017 | 237 | 0.270 |
Why?
|
| Transfection | 4 | 2015 | 5763 | 0.270 |
Why?
|
| Statistics as Topic | 1 | 2013 | 2360 | 0.260 |
Why?
|
| Chromosome Segregation | 3 | 2012 | 230 | 0.260 |
Why?
|
| Eukaryota | 2 | 2017 | 101 | 0.260 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2003 | 136 | 0.260 |
Why?
|
| Research Design | 4 | 2013 | 6214 | 0.260 |
Why?
|
| Cell Separation | 4 | 2015 | 1728 | 0.260 |
Why?
|
| Metabolome | 2 | 2012 | 1009 | 0.250 |
Why?
|
| Regulatory Elements, Transcriptional | 3 | 2013 | 183 | 0.250 |
Why?
|
| Vertebrates | 1 | 2007 | 227 | 0.250 |
Why?
|
| Engineering | 1 | 2005 | 56 | 0.250 |
Why?
|
| Protein Binding | 15 | 2018 | 9344 | 0.250 |
Why?
|
| Genetic Enhancement | 1 | 2005 | 18 | 0.250 |
Why?
|
| Swine | 1 | 2015 | 5997 | 0.250 |
Why?
|
| Access to Information | 3 | 2014 | 317 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2006 | 310 | 0.240 |
Why?
|
| Cells | 1 | 2006 | 166 | 0.240 |
Why?
|
| Risk Management | 3 | 2015 | 558 | 0.240 |
Why?
|
| Base Composition | 5 | 2012 | 291 | 0.240 |
Why?
|
| Biomimetics | 1 | 2006 | 172 | 0.240 |
Why?
|
| G2 Phase | 1 | 2005 | 135 | 0.240 |
Why?
|
| Reproducibility of Results | 19 | 2016 | 20245 | 0.240 |
Why?
|
| Sleep Deprivation | 1 | 2011 | 848 | 0.240 |
Why?
|
| Bacteriophage T7 | 4 | 2014 | 174 | 0.240 |
Why?
|
| Alternative Splicing | 3 | 2007 | 1105 | 0.230 |
Why?
|
| CpG Islands | 1 | 2009 | 1210 | 0.230 |
Why?
|
| Cell Cycle | 6 | 2003 | 2937 | 0.230 |
Why?
|
| Regulon | 2 | 2003 | 71 | 0.230 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2016 | 2525 | 0.230 |
Why?
|
| Amino Acid Motifs | 7 | 2013 | 930 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 3 | 2014 | 4413 | 0.220 |
Why?
|
| Body Size | 1 | 2007 | 463 | 0.220 |
Why?
|
| Cysteine Endopeptidases | 2 | 2004 | 542 | 0.220 |
Why?
|
| Individuality | 1 | 2005 | 307 | 0.220 |
Why?
|
| Geriatrics | 1 | 2008 | 394 | 0.220 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 438 | 0.220 |
Why?
|
| AraC Transcription Factor | 1 | 2003 | 4 | 0.220 |
Why?
|
| Yeasts | 3 | 2017 | 279 | 0.220 |
Why?
|
| Signal Transduction | 10 | 2018 | 23653 | 0.220 |
Why?
|
| Drosophila | 6 | 2008 | 1513 | 0.210 |
Why?
|
| User-Computer Interface | 3 | 2014 | 1406 | 0.210 |
Why?
|
| DNA Cleavage | 2 | 2013 | 56 | 0.210 |
Why?
|
| Genes, rRNA | 1 | 2002 | 73 | 0.210 |
Why?
|
| Hydrochloric Acid | 1 | 2002 | 76 | 0.210 |
Why?
|
| DNA, Superhelical | 1 | 2003 | 51 | 0.210 |
Why?
|
| DNA Mutational Analysis | 6 | 2013 | 4124 | 0.210 |
Why?
|
| Mitochondria | 4 | 2013 | 3682 | 0.210 |
Why?
|
| Sample Size | 2 | 2018 | 848 | 0.210 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2017 | 481 | 0.200 |
Why?
|
| Adenine | 1 | 2008 | 995 | 0.200 |
Why?
|
| Culture Media | 3 | 2016 | 898 | 0.200 |
Why?
|
| Osmotic Pressure | 1 | 2003 | 137 | 0.200 |
Why?
|
| Science | 1 | 2005 | 236 | 0.200 |
Why?
|
| Cell Differentiation | 7 | 2019 | 11684 | 0.200 |
Why?
|
| Reproduction | 2 | 2014 | 646 | 0.200 |
Why?
|
| Internet | 7 | 2017 | 3112 | 0.200 |
Why?
|
| RNA Precursors | 1 | 2003 | 196 | 0.200 |
Why?
|
| Ubiquitin | 2 | 2004 | 843 | 0.200 |
Why?
|
| Cells, Cultured | 10 | 2016 | 19023 | 0.200 |
Why?
|
| Kinetics | 9 | 2013 | 6332 | 0.200 |
Why?
|
| Nucleic Acids | 2 | 2016 | 189 | 0.200 |
Why?
|
| Phosphorothioate Oligonucleotides | 2 | 2012 | 9 | 0.200 |
Why?
|
| Cell Physiological Phenomena | 1 | 2003 | 152 | 0.200 |
Why?
|
| Mycoplasma mycoides | 2 | 2012 | 2 | 0.200 |
Why?
|
| Fungal Proteins | 3 | 2005 | 907 | 0.200 |
Why?
|
| Emotions | 1 | 2014 | 2768 | 0.190 |
Why?
|
| Chromosomes, Fungal | 2 | 2007 | 111 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2006 | 3612 | 0.190 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2013 | 781 | 0.190 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2003 | 2488 | 0.190 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 3 | 1999 | 18 | 0.190 |
Why?
|
| Recombinases | 2 | 2012 | 70 | 0.180 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 2008 | 1057 | 0.180 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2005 | 709 | 0.180 |
Why?
|
| Response Elements | 3 | 2003 | 308 | 0.180 |
Why?
|
| Fluorescent Dyes | 4 | 2015 | 1933 | 0.180 |
Why?
|
| Neurons | 9 | 2019 | 9519 | 0.170 |
Why?
|
| Disease | 2 | 2017 | 673 | 0.170 |
Why?
|
| Polymers | 3 | 2016 | 1632 | 0.170 |
Why?
|
| RNA, Bacterial | 5 | 2009 | 393 | 0.170 |
Why?
|
| Cell Lineage | 4 | 2018 | 2576 | 0.170 |
Why?
|
| Adenosine Deaminase | 3 | 2012 | 253 | 0.160 |
Why?
|
| Receptors, Opioid, mu | 1 | 2000 | 170 | 0.160 |
Why?
|
| Mycoplasma pneumoniae | 3 | 2004 | 43 | 0.160 |
Why?
|
| Caenorhabditis elegans | 4 | 2013 | 1469 | 0.160 |
Why?
|
| RNA, Transfer | 5 | 2014 | 284 | 0.160 |
Why?
|
| Automation | 3 | 2014 | 589 | 0.160 |
Why?
|
| Immediate-Early Proteins | 1 | 2002 | 444 | 0.160 |
Why?
|
| Molecular Imaging | 2 | 2017 | 826 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 2149 | 0.160 |
Why?
|
| Alu Elements | 2 | 2009 | 115 | 0.160 |
Why?
|
| Mammals | 3 | 2011 | 1136 | 0.160 |
Why?
|
| Peptide Termination Factors | 2 | 2016 | 56 | 0.160 |
Why?
|
| Species Specificity | 5 | 2007 | 2417 | 0.160 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 840 | 0.160 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2003 | 606 | 0.160 |
Why?
|
| Embryonic Stem Cells | 2 | 2018 | 1251 | 0.160 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2015 | 843 | 0.160 |
Why?
|
| Sensitivity and Specificity | 9 | 2013 | 14752 | 0.160 |
Why?
|
| Research | 1 | 2007 | 1981 | 0.150 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2017 | 1048 | 0.150 |
Why?
|
| Templates, Genetic | 3 | 2011 | 188 | 0.150 |
Why?
|
| Sulfolobus | 1 | 2018 | 5 | 0.150 |
Why?
|
| Models, Statistical | 7 | 2013 | 5110 | 0.150 |
Why?
|
| Aminobiphenyl Compounds | 1 | 2018 | 5 | 0.150 |
Why?
|
| Photosynthesis | 2 | 2011 | 69 | 0.150 |
Why?
|
| Allosteric Site | 1 | 2018 | 105 | 0.150 |
Why?
|
| Yersinia pestis | 1 | 2018 | 33 | 0.150 |
Why?
|
| Staphylococcus aureus | 2 | 2017 | 1430 | 0.150 |
Why?
|
| Bacteroides | 2 | 2015 | 165 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4592 | 0.150 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 1680 | 0.150 |
Why?
|
| RNA-Binding Proteins | 5 | 2012 | 1891 | 0.140 |
Why?
|
| DNA Modification Methylases | 1 | 1998 | 210 | 0.140 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2015 | 148 | 0.140 |
Why?
|
| Transcription Initiation Site | 2 | 2017 | 190 | 0.140 |
Why?
|
| Microbial Interactions | 2 | 2015 | 74 | 0.140 |
Why?
|
| Fermentation | 2 | 2015 | 143 | 0.140 |
Why?
|
| Gene Dosage | 2 | 2015 | 1222 | 0.140 |
Why?
|
| Phosphorylation | 5 | 2018 | 8317 | 0.140 |
Why?
|
| Deamination | 1 | 2016 | 25 | 0.140 |
Why?
|
| Students | 1 | 2007 | 1744 | 0.140 |
Why?
|
| DNA Restriction Enzymes | 4 | 1992 | 548 | 0.140 |
Why?
|
| Genetic Fitness | 2 | 2015 | 120 | 0.140 |
Why?
|
| Benzoates | 1 | 2018 | 213 | 0.140 |
Why?
|
| Hydrogen Peroxide | 2 | 2002 | 742 | 0.140 |
Why?
|
| Genes, vpr | 1 | 2016 | 19 | 0.140 |
Why?
|
| Cytosine | 2 | 2014 | 213 | 0.130 |
Why?
|
| Conductometry | 1 | 2016 | 10 | 0.130 |
Why?
|
| Porins | 1 | 2016 | 78 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2015 | 18068 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2009 | 4432 | 0.130 |
Why?
|
| Lac Repressors | 1 | 2015 | 15 | 0.130 |
Why?
|
| RNA, Transfer, Ser | 1 | 2015 | 7 | 0.130 |
Why?
|
| RNA, Ribosomal | 1 | 2017 | 227 | 0.130 |
Why?
|
| Genes, Lethal | 1 | 2016 | 224 | 0.130 |
Why?
|
| Chromosomes | 2 | 2011 | 578 | 0.130 |
Why?
|
| Genes, pol | 1 | 2015 | 52 | 0.130 |
Why?
|
| Acyltransferases | 2 | 2014 | 306 | 0.130 |
Why?
|
| Microbial Consortia | 1 | 2015 | 35 | 0.130 |
Why?
|
| Fibroblasts | 3 | 2019 | 4179 | 0.130 |
Why?
|
| Databases, Factual | 8 | 2002 | 8094 | 0.130 |
Why?
|
| Haemophilus influenzae | 1 | 1996 | 177 | 0.130 |
Why?
|
| K562 Cells | 2 | 2018 | 648 | 0.120 |
Why?
|
| Bowhead Whale | 1 | 2015 | 3 | 0.120 |
Why?
|
| Frameshift Mutation | 2 | 2015 | 393 | 0.120 |
Why?
|
| Inositol Oxygenase | 1 | 2014 | 1 | 0.120 |
Why?
|
| Myo-Inositol-1-Phosphate Synthase | 1 | 2014 | 2 | 0.120 |
Why?
|
| Mycobacterium | 1 | 2017 | 252 | 0.120 |
Why?
|
| Biological Science Disciplines | 1 | 2015 | 58 | 0.120 |
Why?
|
| West Nile virus | 1 | 2015 | 77 | 0.120 |
Why?
|
| Genes, Regulator | 3 | 2004 | 373 | 0.120 |
Why?
|
| Art | 1 | 2015 | 67 | 0.120 |
Why?
|
| Cushing Syndrome | 1 | 2017 | 241 | 0.120 |
Why?
|
| Glucaric Acid | 1 | 2014 | 10 | 0.120 |
Why?
|
| Microarray Analysis | 2 | 2009 | 755 | 0.120 |
Why?
|
| Ligands | 3 | 2018 | 3283 | 0.120 |
Why?
|
| Geography | 1 | 2017 | 654 | 0.120 |
Why?
|
| Luciferases, Firefly | 1 | 2014 | 38 | 0.120 |
Why?
|
| Models, Immunological | 2 | 2014 | 518 | 0.120 |
Why?
|
| Repressor Proteins | 4 | 2019 | 2986 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2011 | 1683 | 0.120 |
Why?
|
| Flavanones | 1 | 2014 | 75 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 874 | 0.120 |
Why?
|
| Peptide Elongation Factors | 1 | 2014 | 60 | 0.120 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2015 | 124 | 0.120 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2014 | 88 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 2 | 2015 | 2009 | 0.120 |
Why?
|
| Diploidy | 1 | 2014 | 140 | 0.120 |
Why?
|
| Coculture Techniques | 2 | 2015 | 1342 | 0.120 |
Why?
|
| Acrylamides | 1 | 2016 | 261 | 0.120 |
Why?
|
| Plants, Genetically Modified | 1 | 2014 | 115 | 0.120 |
Why?
|
| Electrophoresis | 3 | 2008 | 226 | 0.120 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.120 |
Why?
|
| VDJ Exons | 1 | 2013 | 11 | 0.110 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2009 | 794 | 0.110 |
Why?
|
| Barth Syndrome | 1 | 2014 | 25 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 262 | 0.110 |
Why?
|
| Eremothecium | 1 | 2013 | 1 | 0.110 |
Why?
|
| Preventive Medicine | 1 | 2015 | 246 | 0.110 |
Why?
|
| Molecular Conformation | 3 | 2012 | 540 | 0.110 |
Why?
|
| RNA, Transfer, Ala | 1 | 2013 | 4 | 0.110 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2017 | 540 | 0.110 |
Why?
|
| Culicidae | 1 | 2014 | 111 | 0.110 |
Why?
|
| Extinction, Biological | 1 | 2013 | 30 | 0.110 |
Why?
|
| Genome, Helminth | 1 | 2013 | 16 | 0.110 |
Why?
|
| Guanosine Triphosphate | 1 | 2014 | 315 | 0.110 |
Why?
|
| 5-Methylcytosine | 1 | 2014 | 147 | 0.110 |
Why?
|
| Lentivirus | 1 | 2016 | 518 | 0.110 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2013 | 111 | 0.110 |
Why?
|
| Clone Cells | 2 | 2014 | 1670 | 0.110 |
Why?
|
| Introns | 2 | 2009 | 969 | 0.110 |
Why?
|
| Systems Theory | 2 | 2004 | 57 | 0.110 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2014 | 211 | 0.110 |
Why?
|
| Soil | 1 | 2014 | 120 | 0.110 |
Why?
|
| Mosquito Control | 1 | 2014 | 110 | 0.110 |
Why?
|
| Chromatin | 5 | 2013 | 2981 | 0.110 |
Why?
|
| Cluster Analysis | 5 | 2011 | 2732 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 3608 | 0.110 |
Why?
|
| Immunoglobulin Heavy Chains | 3 | 1985 | 648 | 0.110 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2013 | 298 | 0.110 |
Why?
|
| DNA, Fungal | 4 | 2005 | 275 | 0.110 |
Why?
|
| Streptomyces | 1 | 2013 | 91 | 0.110 |
Why?
|
| Genome, Plant | 1 | 2013 | 84 | 0.110 |
Why?
|
| Macromolecular Substances | 2 | 2014 | 1435 | 0.110 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2013 | 188 | 0.110 |
Why?
|
| RNA, Small Nuclear | 1 | 2013 | 71 | 0.110 |
Why?
|
| Caspase 9 | 1 | 2013 | 184 | 0.110 |
Why?
|
| Contig Mapping | 1 | 2013 | 56 | 0.110 |
Why?
|
| Brain Mapping | 3 | 2013 | 6739 | 0.110 |
Why?
|
| Bacteriophages | 2 | 2007 | 382 | 0.110 |
Why?
|
| Hydrolysis | 1 | 2014 | 646 | 0.110 |
Why?
|
| Genes, Immunoglobulin | 1 | 2013 | 286 | 0.100 |
Why?
|
| Clindamycin | 1 | 2013 | 138 | 0.100 |
Why?
|
| Air | 1 | 2013 | 187 | 0.100 |
Why?
|
| Ribonucleases | 1 | 2013 | 266 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2016 | 1967 | 0.100 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2015 | 271 | 0.100 |
Why?
|
| Selenocysteine | 1 | 2014 | 127 | 0.100 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2014 | 420 | 0.100 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 902 | 0.100 |
Why?
|
| Oxidation-Reduction | 2 | 2011 | 2226 | 0.100 |
Why?
|
| Exonucleases | 1 | 2012 | 42 | 0.100 |
Why?
|
| Solutions | 1 | 2013 | 410 | 0.100 |
Why?
|
| Gene Duplication | 1 | 2014 | 315 | 0.100 |
Why?
|
| Sarcomeres | 1 | 2015 | 380 | 0.100 |
Why?
|
| Carbocyanines | 1 | 2013 | 177 | 0.100 |
Why?
|
| Acrylic Resins | 2 | 2005 | 135 | 0.100 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 839 | 0.100 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2013 | 241 | 0.100 |
Why?
|
| Casein Kinase II | 1 | 2012 | 121 | 0.100 |
Why?
|
| Molecular Typing | 1 | 2013 | 115 | 0.100 |
Why?
|
| Nucleic Acid Renaturation | 1 | 1991 | 12 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1608 | 0.100 |
Why?
|
| Cyanobacteria | 2 | 2011 | 54 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 4 | 2004 | 2714 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 310 | 0.100 |
Why?
|
| DNA Primase | 1 | 2012 | 110 | 0.100 |
Why?
|
| Costs and Cost Analysis | 3 | 2009 | 1669 | 0.100 |
Why?
|
| Time Factors | 9 | 2017 | 40261 | 0.100 |
Why?
|
| Immunoglobulin Fragments | 1 | 2012 | 84 | 0.100 |
Why?
|
| alpha-Macroglobulins | 1 | 2011 | 60 | 0.100 |
Why?
|
| Point Mutation | 3 | 2012 | 1596 | 0.100 |
Why?
|
| Serine | 1 | 2015 | 831 | 0.100 |
Why?
|
| Public Opinion | 1 | 2015 | 486 | 0.100 |
Why?
|
| Confidentiality | 2 | 2013 | 606 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2017 | 1930 | 0.100 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2011 | 10 | 0.100 |
Why?
|
| Automation, Laboratory | 1 | 2012 | 102 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 350 | 0.100 |
Why?
|
| Ascomycota | 1 | 2012 | 81 | 0.090 |
Why?
|
| Equipment Design | 2 | 2016 | 3530 | 0.090 |
Why?
|
| Hydrocarbons | 1 | 2012 | 105 | 0.090 |
Why?
|
| Amino Acid Substitution | 3 | 2013 | 1742 | 0.090 |
Why?
|
| Industrial Microbiology | 1 | 2011 | 7 | 0.090 |
Why?
|
| Chlorophyta | 1 | 2011 | 15 | 0.090 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 3836 | 0.090 |
Why?
|
| Cell Dedifferentiation | 1 | 2012 | 124 | 0.090 |
Why?
|
| Consensus Sequence | 3 | 2012 | 363 | 0.090 |
Why?
|
| Histidine | 1 | 2012 | 302 | 0.090 |
Why?
|
| Cell Wall | 1 | 2014 | 421 | 0.090 |
Why?
|
| Biofilms | 1 | 2015 | 634 | 0.090 |
Why?
|
| Germ Cells | 1 | 2015 | 644 | 0.090 |
Why?
|
| Behavior | 1 | 2014 | 543 | 0.090 |
Why?
|
| Calibration | 3 | 2006 | 822 | 0.090 |
Why?
|
| Salmonella typhimurium | 1 | 1993 | 347 | 0.090 |
Why?
|
| ROC Curve | 4 | 2013 | 3629 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 2820 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2015 | 812 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 283 | 0.090 |
Why?
|
| Autoantigens | 2 | 2013 | 891 | 0.090 |
Why?
|
| Retroelements | 1 | 2011 | 163 | 0.090 |
Why?
|
| Epistasis, Genetic | 3 | 2016 | 353 | 0.090 |
Why?
|
| Mitochondrial Diseases | 1 | 2014 | 344 | 0.090 |
Why?
|
| Cytosine Deaminase | 1 | 2010 | 65 | 0.090 |
Why?
|
| Catalysis | 1 | 2012 | 768 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2002 | 1369 | 0.090 |
Why?
|
| Vitamin B 12 | 1 | 1993 | 529 | 0.090 |
Why?
|
| HIV Long-Term Survivors | 1 | 2010 | 140 | 0.090 |
Why?
|
| HeLa Cells | 2 | 2016 | 3076 | 0.090 |
Why?
|
| Pentosephosphates | 1 | 2009 | 6 | 0.080 |
Why?
|
| Glycolysis | 2 | 2005 | 838 | 0.080 |
Why?
|
| DNA, Recombinant | 1 | 2010 | 455 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 763 | 0.080 |
Why?
|
| Carbon | 2 | 2011 | 672 | 0.080 |
Why?
|
| Benchmarking | 1 | 2016 | 1059 | 0.080 |
Why?
|
| Peptides | 5 | 2010 | 4353 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2015 | 3447 | 0.080 |
Why?
|
| Escherichia coli K12 | 1 | 2009 | 35 | 0.080 |
Why?
|
| Myocytes, Cardiac | 2 | 2015 | 1682 | 0.080 |
Why?
|
| Protein Subunits | 2 | 2004 | 943 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 1564 | 0.080 |
Why?
|
| Transgenes | 1 | 2013 | 1016 | 0.080 |
Why?
|
| Drug Resistance, Microbial | 2 | 2010 | 830 | 0.080 |
Why?
|
| Transposases | 1 | 2009 | 106 | 0.080 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2013 | 925 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3813 | 0.080 |
Why?
|
| Planets | 1 | 2008 | 7 | 0.080 |
Why?
|
| Sulfites | 1 | 2009 | 83 | 0.080 |
Why?
|
| Sigma Factor | 3 | 2006 | 177 | 0.080 |
Why?
|
| Endoderm | 1 | 2010 | 165 | 0.080 |
Why?
|
| Carrier Proteins | 3 | 2010 | 4939 | 0.080 |
Why?
|
| Computer Systems | 2 | 2016 | 470 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 945 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1973 | 0.080 |
Why?
|
| Ethics Committees, Research | 2 | 2010 | 196 | 0.080 |
Why?
|
| Carbenicillin | 1 | 2008 | 12 | 0.080 |
Why?
|
| Thrombophilia | 1 | 2011 | 308 | 0.080 |
Why?
|
| Biopolymers | 2 | 2006 | 183 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2013 | 463 | 0.080 |
Why?
|
| Multiple Sclerosis | 2 | 2014 | 3250 | 0.080 |
Why?
|
| Pattern Recognition, Automated | 3 | 2006 | 998 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3139 | 0.080 |
Why?
|
| Antiporters | 1 | 2009 | 276 | 0.080 |
Why?
|
| DNA Repair | 2 | 2012 | 2054 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 2003 | 0.070 |
Why?
|
| INDEL Mutation | 3 | 2016 | 267 | 0.070 |
Why?
|
| Cervical Vertebrae | 1 | 2014 | 982 | 0.070 |
Why?
|
| Saliva | 2 | 2010 | 854 | 0.070 |
Why?
|
| Polysaccharides | 2 | 2013 | 1024 | 0.070 |
Why?
|
| RNA, Double-Stranded | 1 | 2009 | 292 | 0.070 |
Why?
|
| Communicable Disease Control | 1 | 2014 | 857 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2013 | 968 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 406 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2009 | 611 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 1399 | 0.070 |
Why?
|
| Light | 1 | 2013 | 1355 | 0.070 |
Why?
|
| beta-Lactamases | 1 | 2009 | 307 | 0.070 |
Why?
|
| Predictive Value of Tests | 5 | 2012 | 15471 | 0.070 |
Why?
|
| Privacy | 1 | 2009 | 233 | 0.070 |
Why?
|
| HLA Antigens | 1 | 2013 | 1336 | 0.070 |
Why?
|
| Gene Order | 1 | 2007 | 168 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2001 | 1216 | 0.070 |
Why?
|
| Autoantibodies | 2 | 2013 | 2120 | 0.070 |
Why?
|
| Genomic Instability | 1 | 2011 | 715 | 0.070 |
Why?
|
| Epigenomics | 1 | 2013 | 961 | 0.070 |
Why?
|
| Security Measures | 1 | 2007 | 83 | 0.070 |
Why?
|
| Antigens, Neoplasm | 2 | 2011 | 2001 | 0.070 |
Why?
|
| Genome-Wide Association Study | 4 | 2014 | 12801 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2011 | 3102 | 0.070 |
Why?
|
| HIV Antibodies | 1 | 2013 | 1341 | 0.070 |
Why?
|
| Adrenal Glands | 1 | 2009 | 557 | 0.070 |
Why?
|
| International Agencies | 1 | 2007 | 244 | 0.070 |
Why?
|
| Protein Folding | 2 | 2001 | 871 | 0.070 |
Why?
|
| Validation Studies as Topic | 1 | 2006 | 162 | 0.070 |
Why?
|
| Carotenoids | 1 | 2009 | 620 | 0.070 |
Why?
|
| Ciprofloxacin | 1 | 2008 | 313 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2592 | 0.060 |
Why?
|
| Cell Shape | 1 | 2007 | 371 | 0.060 |
Why?
|
| Feces | 2 | 2010 | 1510 | 0.060 |
Why?
|
| Prokaryotic Cells | 2 | 2008 | 53 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2015 | 24333 | 0.060 |
Why?
|
| Single-Cell Analysis | 2 | 2015 | 2542 | 0.060 |
Why?
|
| Basal Metabolism | 1 | 2007 | 163 | 0.060 |
Why?
|
| Acetylation | 1 | 2008 | 1056 | 0.060 |
Why?
|
| Genome, Viral | 2 | 2007 | 673 | 0.060 |
Why?
|
| Chromosome Inversion | 1 | 2006 | 119 | 0.060 |
Why?
|
| Base Pairing | 1 | 2006 | 139 | 0.060 |
Why?
|
| Cell Survival | 1 | 2015 | 5793 | 0.060 |
Why?
|
| Mycology | 1 | 2005 | 13 | 0.060 |
Why?
|
| Glucose | 3 | 2011 | 4352 | 0.060 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 684 | 0.060 |
Why?
|
| Models, Animal | 2 | 2014 | 2122 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2013 | 2942 | 0.060 |
Why?
|
| DNA Damage | 1 | 2015 | 2472 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1614 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2012 | 1363 | 0.060 |
Why?
|
| Progesterone | 2 | 2015 | 752 | 0.060 |
Why?
|
| Trypsin | 1 | 2006 | 491 | 0.060 |
Why?
|
| Expressed Sequence Tags | 2 | 2002 | 251 | 0.060 |
Why?
|
| Nitrogen | 1 | 2006 | 345 | 0.060 |
Why?
|
| Melibiose | 1 | 2004 | 3 | 0.060 |
Why?
|
| Energy Metabolism | 3 | 2006 | 2905 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 22379 | 0.060 |
Why?
|
| Empirical Research | 1 | 2005 | 119 | 0.060 |
Why?
|
| Fourier Analysis | 2 | 2007 | 441 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2013 | 1812 | 0.060 |
Why?
|
| Penicillins | 1 | 2008 | 406 | 0.060 |
Why?
|
| Myoblasts | 1 | 2006 | 234 | 0.060 |
Why?
|
| HIV-1 | 2 | 2013 | 6962 | 0.060 |
Why?
|
| Electron Transport Complex IV | 2 | 2002 | 192 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2006 | 2812 | 0.060 |
Why?
|
| Isotope Labeling | 1 | 2006 | 395 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 5342 | 0.060 |
Why?
|
| Methylation | 4 | 1993 | 1078 | 0.060 |
Why?
|
| Mutant Proteins | 2 | 2017 | 488 | 0.060 |
Why?
|
| Ornithine Decarboxylase | 1 | 2004 | 63 | 0.060 |
Why?
|
| Physical Chromosome Mapping | 1 | 2004 | 183 | 0.060 |
Why?
|
| Online Systems | 1 | 2005 | 182 | 0.060 |
Why?
|
| Gels | 1 | 2005 | 423 | 0.060 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2004 | 85 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 3215 | 0.060 |
Why?
|
| DNA-Directed RNA Polymerases | 4 | 2009 | 366 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2000 | 4423 | 0.060 |
Why?
|
| Serine Endopeptidases | 2 | 2007 | 1027 | 0.060 |
Why?
|
| Polyribosomes | 1 | 2003 | 109 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2014 | 1893 | 0.060 |
Why?
|
| Nerve Net | 2 | 2015 | 2359 | 0.060 |
Why?
|
| Homeodomain Proteins | 3 | 2003 | 2431 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 816 | 0.060 |
Why?
|
| Indoles | 1 | 2012 | 1836 | 0.060 |
Why?
|
| Models, Organizational | 1 | 2007 | 549 | 0.060 |
Why?
|
| SMN Complex Proteins | 1 | 2003 | 41 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2013 | 4148 | 0.050 |
Why?
|
| Growth | 1 | 2005 | 366 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3433 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2013 | 3659 | 0.050 |
Why?
|
| Pefloxacin | 1 | 2003 | 3 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3702 | 0.050 |
Why?
|
| Forecasting | 1 | 2012 | 2945 | 0.050 |
Why?
|
| Acrylamide | 1 | 2003 | 59 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2006 | 4251 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 1855 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2005 | 435 | 0.050 |
Why?
|
| Myocardial Contraction | 3 | 2015 | 1526 | 0.050 |
Why?
|
| Novobiocin | 1 | 2003 | 33 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 1894 | 0.050 |
Why?
|
| United States | 6 | 2017 | 73186 | 0.050 |
Why?
|
| Data Collection | 1 | 2012 | 3324 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 1665 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2009 | 1218 | 0.050 |
Why?
|
| DNA, Antisense | 1 | 2002 | 44 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 1002 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2014 | 3473 | 0.050 |
Why?
|
| Government Regulation | 1 | 2007 | 525 | 0.050 |
Why?
|
| Wound Healing | 1 | 2014 | 2815 | 0.050 |
Why?
|
| Acids | 1 | 2003 | 125 | 0.050 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2003 | 108 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2009 | 2885 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2007 | 1714 | 0.050 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8760 | 0.050 |
Why?
|
| Lod Score | 1 | 2003 | 600 | 0.050 |
Why?
|
| DNA Gyrase | 1 | 2003 | 86 | 0.050 |
Why?
|
| Temperature | 2 | 2014 | 2235 | 0.050 |
Why?
|
| Cytoprotection | 1 | 2003 | 200 | 0.050 |
Why?
|
| Saccharomycetales | 1 | 2003 | 74 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2015 | 1065 | 0.050 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2002 | 126 | 0.050 |
Why?
|
| Diffusion | 1 | 2004 | 818 | 0.050 |
Why?
|
| Probability | 2 | 2013 | 2483 | 0.050 |
Why?
|
| Financing, Government | 1 | 2006 | 473 | 0.050 |
Why?
|
| Genetics, Microbial | 1 | 2002 | 53 | 0.050 |
Why?
|
| Staining and Labeling | 2 | 2017 | 1081 | 0.050 |
Why?
|
| Microspheres | 1 | 2005 | 789 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2006 | 997 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 867 | 0.050 |
Why?
|
| Neoplasms | 2 | 2014 | 22389 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2002 | 133 | 0.050 |
Why?
|
| Galactose | 2 | 2004 | 300 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 9080 | 0.050 |
Why?
|
| Schizosaccharomyces | 1 | 2004 | 236 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2010 | 1163 | 0.050 |
Why?
|
| Arabidopsis Proteins | 2 | 2013 | 264 | 0.050 |
Why?
|
| Oxidoreductases | 2 | 2013 | 412 | 0.050 |
Why?
|
| Vaccination | 1 | 2014 | 3438 | 0.050 |
Why?
|
| Spores, Fungal | 1 | 2001 | 90 | 0.050 |
Why?
|
| Internationality | 1 | 2007 | 1008 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2006 | 696 | 0.050 |
Why?
|
| Oligonucleotide Probes | 2 | 2016 | 417 | 0.050 |
Why?
|
| Disulfides | 1 | 2003 | 467 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2001 | 142 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2012 | 4032 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2013 | 125 | 0.050 |
Why?
|
| Water Microbiology | 2 | 2015 | 117 | 0.050 |
Why?
|
| Genetics, Population | 3 | 2014 | 944 | 0.050 |
Why?
|
| Mathematics | 2 | 1993 | 704 | 0.050 |
Why?
|
| Succinimides | 1 | 2001 | 83 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2009 | 1141 | 0.050 |
Why?
|
| Cadmium | 1 | 2002 | 217 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 500 | 0.050 |
Why?
|
| RNA Stability | 1 | 2003 | 321 | 0.040 |
Why?
|
| Linear Models | 1 | 2011 | 5891 | 0.040 |
Why?
|
| Calcium | 1 | 2014 | 5792 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 2003 | 584 | 0.040 |
Why?
|
| src-Family Kinases | 2 | 2013 | 539 | 0.040 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2009 | 944 | 0.040 |
Why?
|
| Ecology | 2 | 2014 | 105 | 0.040 |
Why?
|
| RNA, Antisense | 1 | 2000 | 136 | 0.040 |
Why?
|
| Pharmacogenetics | 2 | 2018 | 683 | 0.040 |
Why?
|
| Nucleic Acid Precursors | 1 | 1979 | 16 | 0.040 |
Why?
|
| Cytochromes | 1 | 1979 | 18 | 0.040 |
Why?
|
| Codon, Initiator | 1 | 2000 | 50 | 0.040 |
Why?
|
| Medical Records | 1 | 2005 | 1411 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2004 | 1320 | 0.040 |
Why?
|
| Methyltransferases | 2 | 1993 | 373 | 0.040 |
Why?
|
| Kidney | 1 | 2015 | 7058 | 0.040 |
Why?
|
| Protein Conformation | 3 | 2016 | 3956 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 1104 | 0.040 |
Why?
|
| Policy | 2 | 2016 | 514 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2012 | 286 | 0.040 |
Why?
|
| DNA Glycosylases | 1 | 2000 | 125 | 0.040 |
Why?
|
| Protein Structure, Quaternary | 1 | 2001 | 426 | 0.040 |
Why?
|
| Male | 15 | 2018 | 365203 | 0.040 |
Why?
|
| Rats | 4 | 2014 | 23786 | 0.040 |
Why?
|
| Myocardium | 2 | 2015 | 4790 | 0.040 |
Why?
|
| Microfluidics | 1 | 2004 | 674 | 0.040 |
Why?
|
| Protein Kinases | 2 | 2013 | 1611 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2017 | 41808 | 0.040 |
Why?
|
| Computer Graphics | 1 | 2001 | 344 | 0.040 |
Why?
|
| Rhombencephalon | 1 | 1999 | 81 | 0.040 |
Why?
|
| Informed Consent | 1 | 2005 | 1010 | 0.040 |
Why?
|
| Energy Intake | 1 | 2007 | 2146 | 0.040 |
Why?
|
| Nuclear Lamina | 1 | 2019 | 46 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2001 | 677 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 2002 | 380 | 0.040 |
Why?
|
| Circular Dichroism | 1 | 1999 | 337 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 2000 | 289 | 0.040 |
Why?
|
| Uterus | 1 | 2003 | 663 | 0.040 |
Why?
|
| DNA-Cytosine Methylases | 1 | 1998 | 17 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 1111 | 0.040 |
Why?
|
| Surface Properties | 2 | 2013 | 1169 | 0.040 |
Why?
|
| Meiosis | 1 | 2000 | 327 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2012 | 10486 | 0.040 |
Why?
|
| Potassium | 1 | 2003 | 1315 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2012 | 507 | 0.040 |
Why?
|
| Nucleic Acid Denaturation | 2 | 1991 | 111 | 0.040 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2000 | 203 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2003 | 1099 | 0.040 |
Why?
|
| Markov Chains | 1 | 2002 | 979 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 859 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2003 | 1074 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2007 | 2433 | 0.040 |
Why?
|
| Female | 15 | 2018 | 397515 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 4413 | 0.040 |
Why?
|
| Isoelectric Point | 1 | 1997 | 76 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 1999 | 255 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2007 | 1335 | 0.040 |
Why?
|
| DNA Transposable Elements | 1 | 2001 | 764 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2001 | 692 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 17173 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2018 | 364 | 0.040 |
Why?
|
| Mycobacterium leprae | 1 | 1997 | 95 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 3780 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1997 | 283 | 0.040 |
Why?
|
| Streptococcus thermophilus | 1 | 2017 | 22 | 0.040 |
Why?
|
| Ethanol | 2 | 2015 | 1331 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 1999 | 275 | 0.040 |
Why?
|
| Peptide Mapping | 1 | 1997 | 260 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2005 | 1904 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 1495 | 0.030 |
Why?
|
| Intellectual Property | 1 | 2016 | 32 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2016 | 1885 | 0.030 |
Why?
|
| Piperazines | 1 | 2007 | 2553 | 0.030 |
Why?
|
| tau Proteins | 1 | 2007 | 2146 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2003 | 3626 | 0.030 |
Why?
|
| Electroporation | 1 | 1997 | 238 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 1731 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2004 | 1541 | 0.030 |
Why?
|
| Sugar Alcohols | 1 | 2015 | 18 | 0.030 |
Why?
|
| Documentation | 1 | 2003 | 917 | 0.030 |
Why?
|
| Enzyme Assays | 1 | 2017 | 103 | 0.030 |
Why?
|
| Cytarabine | 1 | 2018 | 697 | 0.030 |
Why?
|
| Eukaryotic Cells | 2 | 2008 | 192 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2015 | 90 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2009 | 2029 | 0.030 |
Why?
|
| DNA, Viral | 3 | 2002 | 2205 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1495 | 0.030 |
Why?
|
| Fucose | 1 | 2015 | 122 | 0.030 |
Why?
|
| Genes, Viral | 2 | 2007 | 655 | 0.030 |
Why?
|
| Forensic Medicine | 1 | 2015 | 68 | 0.030 |
Why?
|
| West Nile Fever | 1 | 2015 | 77 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2015 | 398 | 0.030 |
Why?
|
| Sucrose | 1 | 2015 | 157 | 0.030 |
Why?
|
| Disaccharides | 1 | 2015 | 170 | 0.030 |
Why?
|
| Air Microbiology | 1 | 2015 | 95 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2007 | 3048 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1997 | 2173 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 466 | 0.030 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2015 | 113 | 0.030 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 980 | 0.030 |
Why?
|
| Digoxin | 1 | 2015 | 246 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2001 | 1531 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2010 | 10276 | 0.030 |
Why?
|
| Doxycycline | 1 | 2016 | 349 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2016 | 592 | 0.030 |
Why?
|
| Models, Theoretical | 3 | 2006 | 3580 | 0.030 |
Why?
|
| Models, Neurological | 2 | 2013 | 1782 | 0.030 |
Why?
|
| Peroxidases | 1 | 1994 | 135 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2002 | 6236 | 0.030 |
Why?
|
| Antibody Diversity | 1 | 2013 | 72 | 0.030 |
Why?
|
| Albumins | 1 | 1997 | 577 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2014 | 190 | 0.030 |
Why?
|
| Peptide Chain Termination, Translational | 1 | 2013 | 29 | 0.030 |
Why?
|
| Liver | 1 | 2010 | 7578 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 2013 | 36 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 347 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 580 | 0.030 |
Why?
|
| Alanine-tRNA Ligase | 1 | 2013 | 7 | 0.030 |
Why?
|
| Heterozygote | 1 | 2000 | 2798 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 2014 | 383 | 0.030 |
Why?
|
| Cobamides | 1 | 1993 | 12 | 0.030 |
Why?
|
| Cryptochromes | 1 | 2013 | 49 | 0.030 |
Why?
|
| Risk | 1 | 2005 | 9621 | 0.030 |
Why?
|
| Patient Selection | 1 | 2005 | 4265 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 848 | 0.030 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2013 | 103 | 0.030 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2014 | 88 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2006 | 859 | 0.030 |
Why?
|
| Carbamyl Phosphate | 1 | 1992 | 3 | 0.030 |
Why?
|
| Digoxigenin | 1 | 1993 | 26 | 0.030 |
Why?
|
| Sorbitol | 1 | 1992 | 61 | 0.030 |
Why?
|
| Pedigree | 2 | 2011 | 4545 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2013 | 253 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 1461 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2014 | 1309 | 0.030 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2013 | 114 | 0.030 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1991 | 14 | 0.030 |
Why?
|
| Germany | 1 | 2014 | 883 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2010 | 4879 | 0.020 |
Why?
|
| Exosomes | 1 | 2017 | 429 | 0.020 |
Why?
|
| Leucine | 1 | 2013 | 548 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1993 | 455 | 0.020 |
Why?
|
| Nanotubes | 1 | 2012 | 83 | 0.020 |
Why?
|
| Salts | 1 | 1991 | 61 | 0.020 |
Why?
|
| Biotin | 1 | 1993 | 256 | 0.020 |
Why?
|
| Sequence Tagged Sites | 1 | 2011 | 96 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2016 | 1762 | 0.020 |
Why?
|
| Neural Pathways | 2 | 2013 | 3120 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2001 | 2421 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 895 | 0.020 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2011 | 24 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1498 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 395 | 0.020 |
Why?
|
| Xanthomonas | 1 | 2011 | 17 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 610 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 1993 | 342 | 0.020 |
Why?
|
| Magnetics | 1 | 2014 | 599 | 0.020 |
Why?
|
| Dengue | 1 | 2014 | 258 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2012 | 221 | 0.020 |
Why?
|
| Mesoderm | 2 | 2006 | 679 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 5707 | 0.020 |
Why?
|
| Technology | 1 | 2013 | 296 | 0.020 |
Why?
|
| Alanine | 1 | 2013 | 614 | 0.020 |
Why?
|
| Biological Transport | 1 | 2015 | 2085 | 0.020 |
Why?
|
| Transformation, Bacterial | 1 | 2010 | 79 | 0.020 |
Why?
|
| Culture Techniques | 1 | 2011 | 530 | 0.020 |
Why?
|
| Benzaldehydes | 1 | 2010 | 59 | 0.020 |
Why?
|
| Desmoplakins | 1 | 2010 | 63 | 0.020 |
Why?
|
| Nanomedicine | 1 | 2013 | 292 | 0.020 |
Why?
|
| Age Factors | 1 | 2007 | 18435 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2013 | 2560 | 0.020 |
Why?
|
| Arabidopsis | 1 | 2013 | 469 | 0.020 |
Why?
|
| Personal Health Services | 1 | 2009 | 24 | 0.020 |
Why?
|
| Arabinose | 1 | 2009 | 31 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1993 | 1705 | 0.020 |
Why?
|
| Korea | 1 | 2009 | 97 | 0.020 |
Why?
|
| Retroviridae | 1 | 2012 | 849 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2009 | 205 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2010 | 325 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2015 | 1469 | 0.020 |
Why?
|
| Cell Movement | 2 | 2014 | 5216 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2009 | 105 | 0.020 |
Why?
|
| Sunlight | 1 | 2011 | 337 | 0.020 |
Why?
|
| Genome, Archaeal | 1 | 2008 | 21 | 0.020 |
Why?
|
| Exobiology | 1 | 2008 | 9 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 246 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2010 | 265 | 0.020 |
Why?
|
| Furans | 1 | 2010 | 202 | 0.020 |
Why?
|
| Extraterrestrial Environment | 1 | 2008 | 26 | 0.020 |
Why?
|
| Raffinose | 1 | 2008 | 57 | 0.020 |
Why?
|
| Antigens | 1 | 2014 | 1444 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2013 | 608 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2015 | 1320 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 457 | 0.020 |
Why?
|
| Sulfuric Acid Esters | 2 | 1985 | 33 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2003 | 1755 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 2010 | 326 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2010 | 7885 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 12253 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5151 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1645 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2003 | 2666 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2010 | 656 | 0.020 |
Why?
|
| Marine Biology | 1 | 2007 | 17 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 474 | 0.020 |
Why?
|
| Synechococcus | 1 | 2007 | 30 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1408 | 0.020 |
Why?
|
| Reference Standards | 1 | 2011 | 1014 | 0.020 |
Why?
|
| Efficiency | 1 | 2011 | 480 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 423 | 0.020 |
Why?
|
| Glycerol | 1 | 2008 | 274 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2007 | 65 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 690 | 0.020 |
Why?
|
| PII Nitrogen Regulatory Proteins | 1 | 2006 | 6 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 942 | 0.020 |
Why?
|
| Photons | 1 | 2011 | 595 | 0.020 |
Why?
|
| Photosystem II Protein Complex | 1 | 2006 | 18 | 0.020 |
Why?
|
| Seawater | 1 | 2007 | 126 | 0.020 |
Why?
|
| Oceans and Seas | 1 | 2006 | 47 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2013 | 1019 | 0.020 |
Why?
|
| Guanine | 2 | 1985 | 280 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2007 | 146 | 0.020 |
Why?
|
| Consensus | 1 | 2016 | 3214 | 0.020 |
Why?
|
| Bioterrorism | 1 | 2007 | 144 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 998 | 0.020 |
Why?
|
| Antioxidants | 1 | 1994 | 1673 | 0.020 |
Why?
|
| Wakefulness | 1 | 2013 | 1284 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2010 | 634 | 0.020 |
Why?
|
| Technology, Pharmaceutical | 1 | 2006 | 84 | 0.020 |
Why?
|
| Therapeutics | 1 | 2006 | 113 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2006 | 272 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2007 | 404 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2007 | 303 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 3913 | 0.020 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2007 | 430 | 0.020 |
Why?
|
| Lipoprotein(a) | 1 | 2010 | 490 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2008 | 567 | 0.020 |
Why?
|
| Family Health | 1 | 2010 | 1255 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1469 | 0.020 |
Why?
|
| Aged | 5 | 2019 | 171786 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2005 | 455 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 21188 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 59739 | 0.010 |
Why?
|
| Electronics | 1 | 2006 | 317 | 0.010 |
Why?
|
| Action Potentials | 1 | 2012 | 1838 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2598 | 0.010 |
Why?
|
| Malaria | 1 | 2014 | 1249 | 0.010 |
Why?
|
| Biological Assay | 1 | 2007 | 628 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13698 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 1985 | 170 | 0.010 |
Why?
|
| Muscle Development | 1 | 2006 | 258 | 0.010 |
Why?
|
| HIV Infections | 1 | 2010 | 17591 | 0.010 |
Why?
|
| Middle Aged | 5 | 2019 | 223737 | 0.010 |
Why?
|
| Brain Diseases | 1 | 2013 | 1558 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2007 | 959 | 0.010 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2003 | 66 | 0.010 |
Why?
|
| Heart Rate | 1 | 2015 | 4217 | 0.010 |
Why?
|
| Adult | 5 | 2015 | 223851 | 0.010 |
Why?
|
| Medical Informatics Computing | 1 | 2003 | 23 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 2003 | 194 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2003 | 43 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2003 | 76 | 0.010 |
Why?
|
| 3' Flanking Region | 1 | 2002 | 14 | 0.010 |
Why?
|
| Hemophilia A | 1 | 2006 | 359 | 0.010 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2003 | 63 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2748 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2003 | 557 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2007 | 686 | 0.010 |
Why?
|
| Metabolomics | 1 | 2012 | 1675 | 0.010 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2002 | 102 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2010 | 1070 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 3626 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 1904 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4076 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2010 | 1568 | 0.010 |
Why?
|
| Nucleosomes | 1 | 2005 | 492 | 0.010 |
Why?
|
| Cattle | 2 | 2000 | 3819 | 0.010 |
Why?
|
| Symporters | 1 | 2004 | 363 | 0.010 |
Why?
|
| Benzamides | 1 | 2007 | 1387 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2003 | 255 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2002 | 265 | 0.010 |
Why?
|
| Viral Load | 1 | 2010 | 3398 | 0.010 |
Why?
|
| Nanoparticles | 1 | 2013 | 1989 | 0.010 |
Why?
|
| Methyl Methanesulfonate | 1 | 2000 | 28 | 0.010 |
Why?
|
| Nuclease Protection Assays | 1 | 2000 | 14 | 0.010 |
Why?
|
| Muscles | 1 | 2006 | 1582 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2452 | 0.010 |
Why?
|
| Drug Discovery | 1 | 2009 | 1068 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2000 | 68 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2003 | 515 | 0.010 |
Why?
|
| Rifampin | 1 | 2003 | 351 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 4978 | 0.010 |
Why?
|
| Renin | 1 | 2003 | 648 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2003 | 613 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 2009 | 1397 | 0.010 |
Why?
|
| Hippocampus | 1 | 2013 | 3782 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 1769 | 0.010 |
Why?
|
| Mutagens | 1 | 2000 | 181 | 0.010 |
Why?
|
| Fibrosis | 1 | 2007 | 2080 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2003 | 710 | 0.010 |
Why?
|
| Public Sector | 1 | 2001 | 266 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 2258 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 3057 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 1469 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3588 | 0.010 |
Why?
|
| Cosmids | 1 | 1997 | 105 | 0.010 |
Why?
|
| Computing Methodologies | 1 | 1997 | 17 | 0.010 |
Why?
|
| Private Sector | 1 | 2001 | 396 | 0.010 |
Why?
|
| Pseudogenes | 1 | 1997 | 104 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1997 | 146 | 0.010 |
Why?
|
| Young Adult | 2 | 2015 | 60131 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2003 | 1337 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 4651 | 0.010 |
Why?
|
| Infertility, Female | 1 | 2003 | 764 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 1977 | 290 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11116 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18354 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1997 | 354 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2000 | 718 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 2960 | 0.010 |
Why?
|
| Solvents | 1 | 1997 | 298 | 0.010 |
Why?
|
| Estradiol | 1 | 2003 | 1952 | 0.010 |
Why?
|
| Mitosis | 1 | 2000 | 1181 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4478 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 1448 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22296 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2007 | 3840 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 1994 | 51 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 1536 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1712 | 0.010 |
Why?
|
| Lasers | 1 | 1997 | 952 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5434 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 30046 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 3450 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 9527 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 42683 | 0.010 |
Why?
|
| Retina | 1 | 2000 | 2661 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 10765 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 5804 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 5831 | 0.000 |
Why?
|
| X-Ray Diffraction | 2 | 1978 | 417 | 0.000 |
Why?
|
| Phenylalanine | 2 | 1978 | 368 | 0.000 |
Why?
|
| Child | 1 | 2013 | 80960 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2000 | 14484 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 89244 | 0.000 |
Why?
|
| Pregnancy | 1 | 2003 | 30265 | 0.000 |
Why?
|
| Chemistry | 1 | 1977 | 327 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1977 | 486 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1985 | 5196 | 0.000 |
Why?
|